Pictet Asset Management (Switzerland)’s Edwards Lifesciences EW Stock Holding History

Pictet Asset Management (Switzerland)’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	$87.9M	Sell	931,625 -62,206	-6%	-$5.41M	0.1%	209
2023 Q1	$82.2M	Buy	993,831 +47,982	+5%	+$3.77M	0.1%	224
2022 Q4	$70.6M	Buy	945,849 +36,069	+4%	+$2.78M	0.1%	227
2022 Q3	$75.2M	Buy	909,780 +31,440	+4%	+$3.03M	0.11%	219
2022 Q2	$83.5M	Sell	878,340 -26,339	-3%	-$2.73M	0.12%	214
2022 Q1	$106M	Sell	904,679 -65,900	-7%	-$7.39M	0.12%	209
2021 Q4	$126M	Buy	970,579 +82,274	+9%	+$9.6M	0.13%	199
2021 Q3	$101M	Buy	+888,305	New	+$101M	0.11%	224

Other funds holding EW

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Pictet Asset Management (Switzerland)'s EW Position: Q2 2023 in Review

Pictet Asset Management (Switzerland) reduced its Edwards Lifesciences (EW) stake by 6.3% in Q2 2023, selling an estimated $5.41M and leaving 931,625 shares worth $87.9M. The position accounts for 0.1% of the portfolio, ranked #209.

Pictet Asset Management (Switzerland) first reported a position in EW in Q3 2021 and has held it in 8 quarters since. The position peaked at $126M in Q4 2021. 1,279 funds tracked by Wall St. Rank hold EW as of Q2 2023.

Pictet Asset Management (Switzerland) held 931,625 shares of Edwards Lifesciences worth $87.9M as of Q2 2023.
Pictet Asset Management (Switzerland) sold 62,206 Edwards Lifesciences shares in Q2 2023, an estimated $5.41M.
Edwards Lifesciences made up 0.1% of Pictet Asset Management (Switzerland)'s portfolio in Q2 2023, its #209 holding.
Pictet Asset Management (Switzerland) first reported a position in Edwards Lifesciences in Q3 2021 and has held it in 8 quarters since.
Pictet Asset Management (Switzerland)'s Edwards Lifesciences position peaked at $126M in Q4 2021.
1,279 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2023.

Based on Pictet Asset Management (Switzerland)'s 13F filing for Q2 2023, filed 10 Aug 2023.